Erythromycin estolate to remain on market.
D000328:Adult; D004917:Erythromycin / Q000031:analogs & derivatives*; D004918:Erythromycin Estolate / Q000009:adverse effects*; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D014481:United States; D014486:United States Food and Drug Administration
D004917:Erythromycin; D004918:Erythromycin Estolate